| Literature DB >> 34968168 |
Jingni Zhang1, Peng Jiang1, Yuan Tu1, Ning Li1, Yuzhen Huang1, Shan Jiang1, Wei Kong1, Rui Yuan1.
Abstract
Intrauterine adhesion (IUA) is an endometrial fibrotic disease with unclear pathogenesis. Increasing evidence suggested the important role of competitive endogenous RNA (ceRNA) in diseases. This study aimed to identify and verify the key long non-coding RNA (lncRNA) associated-ceRNAs in IUA. The lncRNA/mRNA expression file was obtained by transcriptome sequencing of IUA and normal samples. The microRNAs expression date was downloaded from the Gene Expression Omnibus database. Differential expressions of mRNAs, lncRNAs and miRNAs were analyzed using the DESeq2 (2010) R package. Protein interaction network was constructed to explore hub genes. TargetScan and miRanda databases were used to predicate the interaction. Enrichment analysis in Gene Ontology and Kyoto Encyclopedia of Genes and Genomes were performed to identify the biological functions of ceRNAs. Regression analysis of ceRNAs' expression level was performed. There were 915 mRNAs and 418 lncRNAs differentially expressed. AURKA, CDC20, IL6, ASPM, CDCA8, BIRC5, UBE2C, H2AFX, RRM2 and CENPE were identified as hub genes. The ceRNAs network, including 28 lncRNAs, 28 miRNAs, and 299 mRNAs, was constructed. Regression analysis showed a good positive correlation between ceRNAs expression levels (r > 0.700, p < 0.001). The enriched functions include ion transmembrane transport, focal adhesion, cAMP signaling pathway and cGMP-PKG signaling pathway. The novel lncRNA-miRNA-mRNA network in IUA was excavated. Crucial lncRNAs such as ADIRF-AS1, LINC00632, DIO3OS, MBNL1-AS1, MIR1-1HG-AS1, AC100803.2 was involved in the development of IUA. cGMP-PKG signaling pathway and ion transport might be new directions for IUA pathogenesis research.Entities:
Keywords: Intrauterine adhesion; bioinformatics analysis; competitive endogenous RNA network; correlation analysis
Mesh:
Substances:
Year: 2022 PMID: 34968168 PMCID: PMC8805920 DOI: 10.1080/21655979.2021.2017578
Source DB: PubMed Journal: Bioengineered ISSN: 2165-5979 Impact factor: 3.269
Top 15 terms of Gene Ontology analysis of the 915 differentially expressed genes
| Term | Description | Count | |
|---|---|---|---|
| GO:0006323 | DNA packaging | 36 | 1.11E-10 |
| GO:0034401 | chromatin organization involved in regulation of transcription | 25 | 4.08305E-09 |
| GO:0045814 | negative regulation of gene expression, epigenetic | 22 | 2.58071E-08 |
| GO:0030198 | extracellular matrix organization | 44 | 3.47E-08 |
| GO:0003012 | muscle system process | 46 | 1.25E-07 |
| GO:0071824 | protein-DNA complex subunit organization | 34 | 2.5606E-07 |
| GO:0002526 | acute inflammatory response | 19 | 8.97E-07 |
| GO:0050863 | regulation of T cell activation | 39 | 2.17E-06 |
| GO:0040029 | regulation of gene expression, epigenetic | 26 | 3.25783E-06 |
| GO:0010959 | regulation of metal ion transport | 39 | 3.38777E-06 |
| GO:0009311 | oligosaccharide metabolic process | 12 | 6.77125E-06 |
| GO:1903039 | positive regulation of leukocyte cell-cell adhesion | 29 | 2.88932E-05 |
| GO:0062197 | cellular response to chemical stress | 34 | 3.01087E-05 |
| GO:0007249 | I-kappaB kinase/NF-kappaB signaling | 30 | 3.03254E-05 |
| GO:0007080 | mitotic metaphase plate congression | 10 | 4.30341E-05 |
Top 15 terms of Kyoto Encyclopedia of Genes and Genomes pathway analysis of the 915 differentially expressed genes
| Term | Description | Input number | |
|---|---|---|---|
| hsa05322 | Systemic lupus erythematosus | 37 | 6.09192E-20 |
| hsa05169 | Epstein-Barr virus infection | 32 | 1.94502E-11 |
| hsa04621 | NOD-like receptor signaling pathway | 27 | 2.26949E-09 |
| hsa04060 | Cytokine-cytokine receptor interaction | 34 | 9.2017E-09 |
| hsa05200 | Pathways in cancer | 48 | 1.53534E-08 |
| hsa05202 | Transcriptional misregulation in cancer | 26 | 1.65094E-08 |
| hsa05167 | Kaposi sarcoma-associated herpesvirus infection | 25 | 7.4316E-08 |
| hsa04064 | NF-kappa B signaling pathway | 18 | 9.02412E-08 |
| hsa04668 | TNF signaling pathway | 19 | 1.18615E-07 |
| hsa04217 | Necroptosis | 21 | 1.383E-06 |
| hsa05161 | Hepatitis B | 21 | 1.5109E-06 |
| hsa05323 | Rheumatoid arthritis | 15 | 1.89847E-06 |
| hsa05166 | Human T-cell leukemia virus 1 infection | 24 | 2.92875E-06 |
| hsa04620 | Toll-like receptor signaling pathway | 16 | 3.27057E-06 |
| hsa05152 | Tuberculosis | 21 | 3.82689E-06 |
Figure 1.The protein–protein interaction network of differentially expressed genes.
Figure 2.The ceRNAs network in IUA. Diamond-shaped nodes represent miRNAs; Triangle nodes represent lncRNAs; Circular nodes represent mRNAs; Every edge indicates target interaction.
Figure 3.Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway and Gene Ontology (GO) term enrichment analysis of differentially expressed genes (DEGs). (a) All enriched KEGG pathways of DEGs in ceRNAs network. (b) TOP20 enriched GO biological processes of DEGs in ceRNAs network.
Figure 4.Linear regression of ceRNAs’ expression level. Dashed lines represent 95% confidence interval. (a) ADIRF-AS1 vs MAPK10 (hypertrophic cardiomyopathy, n = 22). (b) ADIRF-AS1 vs SLC6A9 (systemic sclerosis, n = 91). (c) ADIRF-AS1 vs HLF (systemic sclerosis, n = 91). (d) ADIRF-AS1 vs AHNAK2 (systemic sclerosis, n = 91). (e) MBNL1-AS1 vs MYL3 (liver fibrosis, n = 124). (E) MBNL1-AS1 vs POPDC3 (liver fibrosis, n = 124). (f) MBNL1-AS1 vs PLN (liver fibrosis, n = 124).